NeuCyte, Inc.
Mountain View, USA
|
Description:
NeuCyte is a preclinical stage biotechnology company focused on developing medicines for the treatment of neurological disorders. Based on its proprietary SynFire® technology for generating human induced pluripotent stem cell (iPSC)-derived induced neural cells, the company has developed a cell-based platform for target identification and validation, efficacy testing, in vitro disease modeling, and neurotoxicity assessment.
NeuCyte is a preclinical stage biotechnology company focused on developing medicines for the treatment of neurological disorders. Based on its proprietary SynFire® technology for generating human induced pluripotent stem cell (iPSC)-derived induced neural cells, the company has developed a cell-based platform for target identification and validation, efficacy testing, in vitro disease modeling, and neurotoxicity assessment.